These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24355750)

  • 61. Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis.
    Mameli G; Poddighe L; Astone V; Delogu G; Arru G; Sotgiu S; Serra C; Dolei A
    J Virol Methods; 2009 Oct; 161(1):98-106. PubMed ID: 19505508
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Commentary on J Clausen's review--endogenous retroviruses in MS.
    Garson JA
    Int MS J; 2003 Apr; 10(1):20-1. PubMed ID: 12906766
    [No Abstract]   [Full Text] [Related]  

  • 63. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases.
    Antony JM; Izad M; Bar-Or A; Warren KG; Vodjgani M; Mallet F; Power C
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1253-9. PubMed ID: 17209768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification and phylogeny of novel human endogenous retroviral sequences belonging to the HERV-W family on the human X chromosome.
    Kim H; Crow TJ
    Arch Virol; 1999; 144(12):2403-13. PubMed ID: 10664393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Retrovirus superantigen hypothesis of multiple sclerosis].
    Emmer A; Staege MS; Kornhuber ME
    Nervenarzt; 2013 Oct; 84(10):1245-6. PubMed ID: 24052080
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis.
    Petersen T; Møller-Larsen A; Thiel S; Brudek T; Hansen TK; Christensen T
    J Neuroimmunol; 2009 Oct; 215(1-2):108-16. PubMed ID: 19766328
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential Expression of HERV-W in Peripheral Blood in Multiple Sclerosis and Healthy Patients in Two Different Ethnic Groups.
    Tarlinton R; Wang B; Morandi E; Gran B; Khaiboullin T; Martynova E; Rizvanov A; Khaiboullina S
    Front Pharmacol; 2019; 10():1645. PubMed ID: 32076404
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface.
    Leboyer M; Tamouza R; Charron D; Faucard R; Perron H
    World J Biol Psychiatry; 2013 Mar; 14(2):80-90. PubMed ID: 21936762
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis.
    Serra C; Mameli G; Arru G; Sotgiu S; Rosati G; Dolei A
    J Neurovirol; 2003 Dec; 9(6):637-43. PubMed ID: 14602576
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis.
    Sotgiu S; Mameli G; Serra C; Zarbo IR; Arru G; Dolei A
    Mult Scler; 2010 Oct; 16(10):1248-51. PubMed ID: 20685761
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Up-to-date knowledge about the association between multiple sclerosis and the reactivation of human endogenous retrovirus infections.
    Arneth B
    J Neurol; 2018 Aug; 265(8):1733-1739. PubMed ID: 29423611
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672].
    Perron H; Germi R; Bernard C; Garcia-Montojo M; Deluen C; Farinelli L; Faucard R; Veas F; Stefas I; Fabriek BO; Van-Horssen J; Vander-Valk P; Gerdil C; Mancuso R; Saresella M; Clerici M; Marcel S; Creange A; Cavaretta R; Caputo D; Arru G; Morand P; Lang AB; Sotgiu S; Ruprecht K; Rieckmann P; Villoslada P; Chofflon M; Boucraut J; Pelletier J; Hartung HP
    Mult Scler; 2013 May; 19(6):831-2. PubMed ID: 23658240
    [No Abstract]   [Full Text] [Related]  

  • 73. HERVs: have we been here before?
    Christensen T; Giovannoni G
    Mult Scler; 2013 May; 19(6):827-9. PubMed ID: 23658239
    [No Abstract]   [Full Text] [Related]  

  • 74. Haplotypes of the endogenous retrovirus HRES-1 in multiple sclerosis patients and healthy control subjects of Shanghai Chinese origin.
    Rasmussen HB; Kelly MA; Francis DA; Clausen J
    Dis Markers; 1998 Feb; 13(4):251-5. PubMed ID: 9553740
    [No Abstract]   [Full Text] [Related]  

  • 75. Editorial: The Past and the Future of Human Immunity Under Viral Evolutionary Pressure.
    Hurst TP; Magiorkinis G
    Front Immunol; 2019; 10():2340. PubMed ID: 31632408
    [No Abstract]   [Full Text] [Related]  

  • 76. Motor neuron disease: Human endogenous retrovirus-K activation is implicated in amyotrophic lateral sclerosis.
    Wood H
    Nat Rev Neurol; 2015 Dec; 11(12):666. PubMed ID: 26481297
    [No Abstract]   [Full Text] [Related]  

  • 77. Ancient foes and helpers: Research sheds new light on the role that retroviruses play in disease, innate immunity and neural plasticity.
    Hunter P
    EMBO Rep; 2019 Sep; 20(9):e48911. PubMed ID: 31393048
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A retroviral implication in multiple sclerosis?
    Christensen T; Møller-Larsen A; Haahr S
    Trends Microbiol; 1994 Sep; 2(9):332-6. PubMed ID: 7812667
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human endogenous retroviruses and the nervous system.
    Douville RN; Nath A
    Handb Clin Neurol; 2014; 123():465-85. PubMed ID: 25015500
    [No Abstract]   [Full Text] [Related]  

  • 80. Porcine endogenous retrovirus infection of human peripheral blood mononuclear cells.
    Denner J
    Xenotransplantation; 2015; 22(2):151-2. PubMed ID: 25511997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.